Oxford University and AstraZeneca have acknowledged a manufacturing error meant some trial participants received only a partial dose of their experimental Covid-19 vaccine.The announcement has raised questions about why researchers did not mention the error when they claimed the jab was “highly effective” just days ago.HuffPost is now a part of Verizon Media
索利歐表示，預計新一輪試驗不會延誤英國和歐盟監管部門的批准，要獲得美國食品暨藥物管理局（FDA）的批准則可能需要更長時間，因為FDA不太可能在疫苗於其他地方進行研究下加以批准，尤其是研究結果遭質疑時。